Please use this identifier to cite or link to this item:
Year of Publication: 
[Journal:] Health Economics Review [ISSN:] 2191-1991 [Volume:] 1 [Issue:] 2 [Publisher:] Springer [Place:] Heidelberg [Year:] 2011 [Pages:] 1-10
Springer, Heidelberg
Health economists have studied the determinants of the expected value of health status as a function of medical and non-medical inputs, often finding small marginal effects of the former. However, medical inputs may have an additional benefit in the form of a reduced variability of health status. Using the standard deviation of life expectancy in 24 OECD countries between 1960 and 2005, a 10 percent increase of health care expenditure is associated with a decrease of an estimated 0.42 percent. Willingness to pay for such a reduction of uncertainty may well exceed the extra health care expenditure in the United States and Switzerland. This implies that even in these two countries with very high health care expenditure per capita, flat-of-the-curve medicine need not be wasteful.
production of health
control over health status
willingness to pay
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 

Files in This Item:

Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.